XML 52 R33.htm IDEA: XBRL DOCUMENT v3.20.1
FAIR VALUE DISCLOSURES (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Assets and Liabilities Measured at Fair Value on Recurring Basis
Fair Value Measurements at March 31, 2020 (1)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Assets
 
 
 
 
 
 
 
Investments
 
 
 
 
 
 
 
Fixed maturities, AFS:
 
 
 
 
 
 
 
Corporate (2)
$

 
$
47,137

 
$
1,185

 
$
48,322

U.S. Treasury, government and agency

 
18,633

 

 
18,633

States and political subdivisions

 
689

 
36

 
725

Foreign governments

 
498

 

 
498

Residential mortgage-backed (3)

 
184

 

 
184

Asset-backed (4)

 
1,356

 
40

 
1,396

Commercial mortgage-backed

 
39

 

 
39

Redeemable preferred stock
252

 
272

 

 
524

Total fixed maturities, AFS
252

 
68,808

 
1,261

 
70,321

Other equity investments
12

 

 
87

 
99

Trading securities
438

 
6,059

 
37

 
6,534

Other invested assets:
 
 
 
 
 
 


Short-term investments

 
142

 

 
142

Assets of consolidated VIEs/VOEs
98

 
365

 
16

 
479

Swaps

 
2,594

 

 
2,594

Credit default swaps

 
4

 

 
4

Futures
(3
)
 

 

 
(3
)
Options

 
(539
)
 

 
(539
)
Swaptions

 

 

 

Total other invested assets
95

 
2,566

 
16

 
2,677

Cash equivalents
9,026

 

 

 
9,026

Segregated securities

 
2,013

 

 
2,013

GMIB reinsurance contracts asset

 

 
2,823

 
2,823

Separate Accounts assets (5)
102,853

 
2,632

 

 
105,485

Total Assets
$
112,676

 
$
82,078

 
$
4,224

 
$
198,978

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
GMxB derivative features’ liability
$

 
$

 
$
9,727

 
$
9,727

SCS, SIO, MSO and IUL indexed features’ liability

 
(940
)
 

 
(940
)
Liabilities of consolidated VIEs and VOEs
1

 
19

 

 
20

Contingent payment arrangements

 

 
24

 
24

Total Liabilities
$
1

 
$
(921
)
 
$
9,751

 
$
8,831


______________
(1)
Excludes amounts reclassified as Held-for-Sale.
(2)
Corporate fixed maturities includes both public and private issues.
(3)
Includes publicly traded agency pass-through securities and collateralized obligations.
(4)
Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
(5)
Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At March 31, 2020, the fair value of such investments was $361 million.
Fair Value Measurements at December 31, 2019 (1)
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
Assets
 
 
 
 
 
 
 
Investments
 
 
 
 
 
 
 
Fixed maturities, AFS:
 
 
 
 
 
 
 
Corporate (2)
$

 
$
46,942

 
$
1,257

 
$
48,199

U.S. Treasury, government and agency

 
15,394

 

 
15,394

States and political subdivisions

 
666

 
39

 
705

Foreign governments

 
492

 

 
492

Residential mortgage-backed (3)

 
191

 

 
191

Asset-backed (4)

 
749

 
100

 
849

Commercial mortgage-backed (3)

 

 

 

Redeemable preferred stock
239

 
274

 

 
513

Total fixed maturities, AFS
239

 
64,708

 
1,396

 
66,343

Other equity investments
13

 

 
97

 
110

Trading securities
500

 
6,495

 
36

 
7,031

Other invested assets:
 
 
 
 
 
 


Short-term investments

 
490

 

 
490

Assets of consolidated VIEs/VOEs
132

 
457

 
17

 
606

Swaps

 
(327
)
 

 
(327
)
Credit default swaps

 
15

 

 
15

Options

 
3,346

 

 
3,346

Swaptions

 
16

 

 
16

Total other invested assets
132

 
3,997

 
17

 
4,146

Cash equivalents
3,497

 

 

 
3,497

Segregated securities

 
1,095

 

 
1,095

GMIB reinsurance contracts asset

 

 
2,139

 
2,139

Separate Accounts assets (5)
123,432

 
2,892

 

 
126,324

Total Assets
$
127,813

 
$
79,187

 
$
3,685

 
$
210,685

 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
GMxB derivative features’ liability
$

 
$

 
$
8,432

 
$
8,432

SCS, SIO, MSO and IUL indexed features’ liability

 
3,268

 

 
3,268

Liabilities of consolidated VIEs and VOEs
1

 
9

 

 
10

Contingent payment arrangements

 

 
23

 
23

Total Liabilities
$
1

 
$
3,277

 
$
8,455

 
$
11,733


______________
(1)
Excludes amounts reclassified as Held-for-Sale.
(2)
Corporate fixed maturities includes both public and private issues.
(3)
Includes publicly traded agency pass-through securities and collateralized obligations.
(4)
Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
(5)
Separate Accounts assets included in the fair value hierarchy exclude investments in entities that calculate NAV per share (or its equivalent) as a practical expedient. Such investments excluded from the fair value hierarchy include investments in real estate and commercial mortgages. At December 31, 2019, the fair value of such investments was $356 million.
Reconciliation of Assets and Liabilities at Level 3
The tables below present reconciliations for all Level 3 assets and liabilities at March 31, 2020 and 2019, respectively:
Level 3 Instruments - Fair Value Measurements
 
Corporate
 
State and
Political
Subdivisions
 
Asset-
backed
 
(in millions)
Balance, January 1, 2020
$
1,257

 
$
39

 
$
100

Total gains and (losses), realized and unrealized, included in:
 
 
 
 
 
Net income (loss) as:
 
 
 
 
 
Net investment income (loss)
1

 

 

Investment gains (losses), net
(2
)
 

 

Subtotal
(1
)
 

 

Other comprehensive income (loss)
(61
)
 
(3
)
 
(8
)
Purchases
61

 

 
48

Sales
(45
)
 

 

Transfers into Level 3 (1)

 

 

Transfers out of Level 3 (1)
(26
)
 

 
(100
)
Balance, March 31, 2020
$
1,185

 
$
36

 
$
40

 
 
 
 
 
 
Balance, January 1, 2019
$
1,186

 
$
39

 
$
519

Total gains and (losses), realized and unrealized, included in:
 
 
 
 
 
Net income (loss) as:
 
 
 
 
 
Net investment income (loss)
1

 

 

Investment gains (losses), net

 

 

Subtotal
1

 

 

Other comprehensive income (loss)
9

 
1

 
4

Purchases
70

 

 
11

Sales
(34
)
 

 

Transfers into Level 3 (1)
17

 

 

Transfers out of Level 3 (1)
(69
)
 

 

Balance, March 31, 2019
$
1,180

 
$
40

 
$
534

_____________
(1)
Transfers into/out of the Level 3 classification are reflected at beginning of period fair values.
 
Other Equity Investments
 
GMIB Reinsurance
 Contract Asset
 
Separate Accounts Assets
 
GMxB Derivative Features Liability
 
Contingent Payment Arrangement
 
(in millions)
Balance, January 1, 2020
$
150

 
$
2,139

 
$

 
$
(8,432
)
 
$
(23
)
Realized and unrealized gains (losses), included in Net income (loss) as:
 
 
 
 
 
 
 
 
 
Investment gains (losses), net
7

 

 

 

 

Net derivative gains (losses), excluding non-performance risk

 
955

 

 
(3,884
)
 

Non-performance risk (1)

 
(229
)
 

 
2,686

 

Total realized and unrealized gains (losses)
7

 
726

 

 
(1,198
)
 

Other comprehensive income (loss)
(7
)
 

 

 

 

Purchases (2)
2

 
10

 

 
(111
)
 

Sales (3)
(11
)
 
(20
)
 

 
14

 

Settlements (4)

 

 

 

 

Change in estimate (5)

 
(32
)
 

 

 

Activity related to consolidated VIEs/VOEs
(1
)
 

 

 

 
(1
)
Transfers into Level 3 (6)

 

 

 

 

Transfers out of Level 3 (6)

 

 

 

 

Balance, March 31, 2020
$
140

 
$
2,823

 
$

 
$
(9,727
)
 
$
(24
)
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2019
$
165

 
$
1,732

 
$
21

 
$
(5,614
)
 
$
(7
)
Realized and unrealized gains (losses), included in Net income (loss) as:
 
 
 
 
 
 
 
 
 
Investment gains (losses), net

 

 

 

 

Net derivative gains (losses), excluding non-performance risk

 
(11
)
 

 
63

 

Non-performance risk (1)

 
29

 

 
(470
)
 

Total realized and unrealized gains (losses)

 
18

 

 
(407
)
 

Other comprehensive income (loss)

 

 

 

 

Purchases (2)
2

 
11

 
4

 
(111
)
 

Sales (3)

 
(21
)
 

 
6

 

Settlements (4)

 

 
(1
)
 

 

Change in estimate

 

 

 

 

Activity related to consolidated VIEs/VOEs
(1
)
 

 

 

 

Transfers into Level 3 (6)

 

 

 

 

Transfers out of Level 3 (6)
(29
)
 

 
(1
)
 

 

Balance, March 31, 2019
$
137

 
$
1,740

 
$
23

 
$
(6,126
)
 
$
(7
)
______________
(1)
The Company’s non-performance risk is recorded through Net derivative gains (losses).
(2)
For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee.
(3)
For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid.
(4)
For contingent payment arrangements, it represents payments under the arrangement.
(5)
For the GMIB reinsurance contract asset, represents a transfer from amounts due from reinsurers.
(6)
Transfers into/out of the Level 3 classification are reflected at beginning-of-period fair values.
The table below details changes in unrealized gains (losses) for the three months ended March 31, 2020 and 2019 by category for Level 3 assets and liabilities still held at March 31, 2020 and 2019, respectively.
Change in Unrealized Gains (Losses) for Level 3 Instruments
 
Net Income (Loss)
 
 
 
Net Derivative Gains (Losses)
 
OCI
 
(in millions)
Held at March 31, 2020:
 
 
 
Change in unrealized gains (losses):
 
 
 
Fixed maturities, AFS
 
 
 
Corporate
$

 
$
(61
)
State and political subdivisions

 
(2
)
Asset-backed

 
(8
)
Total fixed maturities, AFS

 
(71
)
GMIB reinsurance contracts
726

 

GMxB derivative features liability
(1,198
)
 

Total
$
(472
)
 
$
(71
)
 
 
 
 
Held at March 31, 2019:
 
 
 
Change in unrealized gains (losses):
 
 
 
Fixed maturities, AFS
 
 
 
Corporate
$

 
$
9

State and political subdivisions

 
1

Asset-backed

 
4

Total fixed maturities, AFS

 
14

GMIB reinsurance contracts
18

 

GMxB derivative features liability
(408
)
 

Total
$
(390
)
 
$
14


Quantitative Information About Level 3 Fair Value Measurement
The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities at March 31, 2020 and December 31, 2019, respectively.
Quantitative Information about Level 3 Fair Value Measurements at March 31, 2020
 
Fair
Value
 
Valuation
Technique
 
Significant
Unobservable Input
 
Range
 
Weighted Average (2)
 
(in millions)
 
 
Assets:
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 
Fixed maturities, AFS:
 
 
 
 
 
 
 
 
 
Corporate
$
63

 
Matrix pricing model
 
Spread over Benchmark
 
15 - 580 bps
 
264 bps
 
1,034

 
Market comparable 
companies
 
EBITDA multiples
Discount rate
Cash flow multiples
 
3.2x - 31.5x
6.0% - 25.2%
0.8x - 25.8x
 
14.0x
10.1%
11.1x
Other equity investments
37

 
Discounted cash flow
 
Earnings multiple
Discount factor
Discount years
 
8.0x
10.0%
11
 
 
GMIB reinsurance contract asset
2,823

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates
Volatility rates - Equity
Mortality rates (1):
Ages 0 - 40
Ages 41 - 60
Ages 61 - 115
 
144 - 293 bps
0.8% - 10%
0.0% - 8.0%
0.0% - 49.0%
20.0% - 37.0%

0.01% - 0.18%
0.07% - 0.54%
0.42% - 42.20%
 
233 bps
1.56%
1.19%
6.59%
27%

All Ages 2.71%

 
Fair
Value
 
Valuation
Technique
 
Significant
Unobservable Input
 
Range
 
Weighted Average (2)
Liabilities:
 
 
 
 
 
 
 
 
 
GMIBNLG
9,308

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization
Mortality rates (1):
Ages 0 - 40
Ages 41 - 60
Ages 61 - 115
 
304 bps
0.8% - 19.9%
0.3% - 11.0%
0.0% - 100%

0.01% - 0.19%
0.06% - 0.53%
0.41% - 41.39%
 

2.75%
1.21%
6.46%

All Ages 1.34%
Assumed GMIB Reinsurance Contracts
218

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates (Age 0 - 85)
Withdrawal rates (Age 86+)
Utilization rates
Volatility rates - Equity
 
 201 - 419 bps
1.1% - 11.1%
0.6% - 22.2%
1.1% - 100.0%
0.0% - 30.0%
20.0% - 37.0%
 
357 bps
1.56%
All Ages 1.19%

6.59%
27%
GWBL/GMWB
146

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates

Volatility rates - Equity
 
304 bps
0.8% - 10.0%
0.0% - 7.0%
100% after starting
20.0% - 37.0%
 

1.75%
1.19%


27%
GIB
38

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates
Volatility rates - Equity
 
304 bps
1.2% - 19.9%
0.0% - 8.0%
0.0% - 100.0%
20.0% - 37.0%
 

1.75%
1.19%
6.59%
27%
GMAB
17

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Volatility rates - Equity
 
304 bps
1.0% - 10.0%
20.0% - 37.0%
 

1.75%
27%
______________
(1)
Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
(2)
For Lapses, Withdrawals, and Utilizations the rates were weighted by counts, for Mortality weighted average rates are shown for all ages combined and for Withdrawals the weighted averages were based on an estimated split of partial withdrawal and dollar-for-dollar withdrawals.

Quantitative Information about Level 3 Fair Value Measurements at December 31, 2019
 
Fair
Value
 
Valuation
Technique
 
Significant
Unobservable Input
 
Range
 
Weighted Average
 
(in millions)
 
 
Assets:
 
 
 
 
 
 
 
 
 
Investments:
 
 
 
 
 
 
 
 
 
Fixed maturities, AFS:
 
 
 
 
 
 
 
 
 
Corporate
$
57

 
Matrix pricing model
 
Spread over benchmark
 
65 - 580 bps
 
184 bps
 
1,025

 
Market comparable companies
 
EBITDA multiples
Discount rate
Cash flow multiples
 
3.3x - 56.7x
3.9% - 16.5%
0.8x - 48.1x
 
14.3x
10.0%
10.7x
Other equity investments
36

 
Discounted cash flow
 
Earnings multiple
Discounts factor
Discount years
 
8.0x
10.0%
11
 
 
GMIB reinsurance contract asset
2,139

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates
Volatility rates - Equity
Mortality rates (1):
Ages 0 - 40
Ages 41 - 60
Ages 60 - 115
 
55 - 109 bps
0.8% - 10%
0.0% - 8.0%
0.0% - 49.0%
9.0% - 30.0%

0.01% - 0.18%
0.07% - 0.54%
0.42% - 42.20%
 
 

 
Fair
Value
 
Valuation
Technique
 
Significant
Unobservable Input
 
Range
 
Weighted Average
Liabilities:
 
 
 
 
 
 
 
 
 
GMIBNLG
8,128

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Annuitization rates
Mortality rates (1):
Ages 0 - 40
Ages 41 - 60
Ages 60 - 115
 
124 bps
0.8% - 19.9%
0.3% - 11.0%
0.0% - 100%

0.01% - 0.19%
0.06% - 0.53%
0.41% - 41.39%
 
 
Assumed GMIB Reinsurance Contracts
186

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates (Age 0 - 85)
Withdrawal rates (Age 86+)
Utilization rates
Volatility rates - Equity
 
61 - 141 bps
1.1% - 11.1%
0.6% - 22.2%
1.1% - 100.0%
0.0% - 30.0%
9.0% - 30.0%
 
 
GWBL/GMWB
109

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates

Volatility rates - Equity
 
124 bps
0.8% - 10.0%
0.0% - 7.0%
100% after starting
9.0% - 30.0%
 
 
GIB
5

 
Discounted cash flow
 
Non-performance risk
Lapse rates
Withdrawal rates
Utilization rates
Volatility rates - Equity
 
124 bps
1.2% - 19.9%
0.0% - 8.0%
0.0% - 100.0%
9.0% - 30.0%
 
 
GMAB
4

 
Discounted cash flow
 
Lapse rates
Volatility rates - Equity
 
1.0% - 10.0%
9.0% - 30.0%
 
 

______________
(1)
Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
Fair Value Disclosure Financial Instruments Not Carried At Fair Value Note 4
The carrying values and fair values at March 31, 2020 and December 31, 2019 for financial instruments not otherwise disclosed in Note 3 and Note 4 are presented in the table below.
Carrying Values and Fair Values for Financial Instruments Not Otherwise Disclosed
 
Carrying
Value
 
Fair Value
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(in millions)
March 31, 2020:
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
$
12,123

 
$

 
$

 
$
12,134

 
$
12,134

Policy loans (1)
$
3,720

 
$

 
$

 
$
4,686

 
$
4,686

Policyholders’ liabilities: Investment contracts (1)
$
2,089

 
$

 
$

 
$
2,201

 
$
2,201

FHLBNY funding agreements
$
6,759

 
$

 
$
6,835

 
$

 
$
6,835

Short-term and long-term debt
$
4,217

 
$

 
$
4,201

 
$

 
$
4,201

Separate Accounts liabilities
$
7,563

 
$

 
$

 
$
7,563

 
$
7,563

 
 
 
 
 
 
 
 
 
 
December 31, 2019:
 
 
 
 
 
 
 
 
 
Mortgage loans on real estate
$
12,107

 
$

 
$

 
$
12,334

 
$
12,334

Policy loans (1)
$
3,735

 
$

 
$

 
$
4,707

 
$
4,707

Policyholders’ liabilities: Investment contracts (1)
$
2,056

 
$

 
$

 
$
2,167

 
$
2,167

FHLBNY funding agreements
$
6,909

 
$

 
$
6,957

 
$

 
$
6,957

Short-term and long-term debt
$
4,111

 
$

 
$
4,476

 
$

 
$
4,476

Separate Accounts liabilities
$
9,041

 
$

 
$

 
$
9,041

 
$
9,041

______________
(1)
Excludes amounts reclassified as Held-f